Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Limited data is available to guide the choice of the conditioning regimen for patients with acute myeloid leukemia (AML) undergoing transplant with persistent disease.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 April 2019
|
| In: |
Journal of hematology & oncology
Year: 2019, Volume: 12, Pages: 1-7 |
| ISSN: | 1756-8722 |
| DOI: | 10.1186/s13045-019-0727-4 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1186/s13045-019-0727-4
|
| Author Notes: | Francesco Saraceni, Myriam Labopin, Arne Brecht, Nicolaus Kröger, Matthias Eder, Johanna Tischer, Hélène Labussière-Wallet, Hermann Einsele, Dietrich Beelen, Donald Bunjes, Dietger Niederwieser, Tilmann Bochtler, Bipin N. Savani, Mohamad Mohty, & Arnon Nagler |
| Summary: | Limited data is available to guide the choice of the conditioning regimen for patients with acute myeloid leukemia (AML) undergoing transplant with persistent disease. |
|---|---|
| Item Description: | Gesehen am 17.07.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1756-8722 |
| DOI: | 10.1186/s13045-019-0727-4 |